Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis

Objectives Gastric colonisation with intestinal flora (IF) has been shown to promote Helicobacter pylori (Hp)-associated gastric cancer. However, it is unknown if the mechanism involves colonisation with specific or diverse microbiota secondary to gastric atrophy. Design Gastric colonisation with Altered Schaedler's flora (ASF) and Hp were correlated with pathology, immune responses and mRNA expression for proinflammatory and cancer-related genes in germ-free (GF), Hp monoassociated (mHp), restricted ASF (rASF; 3 species), and specific pathogen-free (complex IF), hypergastrinemic INS-GAS mice 7 months postinfection. Results Male mice cocolonised with rASFHp or IFHp developed the most severe pathology. IFHp males had the highest inflammatory responses, and 40% developed invasive gastrointestinal intraepithelial neoplasia (GIN). Notably, rASFHp colonisation was highest in males and 23% developed invasive GIN with elevated expression of inflammatory biomarkers. Lesions were less severe in females and none developed GIN. Gastritis in male rASFHp mice was accompanied by decreased Clostridum species ASF356 and Bacteroides species ASF519 colonisation and an overgrowth of Lactobacillus murinus ASF361, supporting that inflammation-driven atrophy alters the gastric niche for GI commensals. Hp colonisation also elevated expression of IL-11 and cancer-related genes, Ptger4 and Tgf-β, further supporting that Hp infection accelerates gastric cancer development in INS-GAS mice. Conclusions rASFHp colonisation was sufficient for GIN development in males, and lower GIN incidence in females was associated with lower inflammatory responses and gastric commensal and Hp colonisation. Colonisation efficiency of commensals appears more important than microbial diversity and lessens the probability that specific gastrointestinal pathogens are contributing to cancer risk.

[1]  Leah M. Feazel,et al.  Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity , 2013, Science.

[2]  K. Ottemann,et al.  The Degree of Helicobacter pylori-Triggered Inflammation Is Manipulated by Preinfection Host Microbiota , 2013, Infection and Immunity.

[3]  S. Nagini,et al.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. , 2012, World journal of gastrointestinal oncology.

[4]  Bin Tean Teh,et al.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.

[5]  Menghong Sun,et al.  Potentially Functional Variants of PLCE1 Identified by GWASs Contribute to Gastric Adenocarcinoma Susceptibility in an Eastern Chinese Population , 2012, PloS one.

[6]  Wen Tan,et al.  A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1 , 2011, Nature Genetics.

[7]  A. Giraud,et al.  IL-11 is a parietal cell cytokine that induces atrophic gastritis , 2011, Gut.

[8]  Howard C. Tenenbaum,et al.  Bacterial biogeography of the human digestive tract , 2011, Scientific reports.

[9]  Li Yang,et al.  Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. , 2011, Gastroenterology.

[10]  M. Lopes,et al.  Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells , 2011, Proceedings of the National Academy of Sciences.

[11]  T. Schoeb,et al.  Helicobacter felis–Associated Gastric Disease in Microbiota-Restricted Mice , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  R. Fry,et al.  17β-Estradiol and Tamoxifen Prevent Gastric Cancer by Modulating Leukocyte Recruitment and Oncogenic Pathways in Helicobacter Pylori–Infected INS-GAS Male Mice , 2011, Cancer Prevention Research.

[13]  R. Fry,et al.  17(lowercase beta)-estradiol and Tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice , 2011 .

[14]  Nicola C. Reading,et al.  The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis , 2011, Front. Microbio..

[15]  Eoin L Brodie,et al.  Structure of the human gastric bacterial community in relation to Helicobacter pylori status , 2011, The ISME Journal.

[16]  E. Kuipers,et al.  Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil , 2011, Gut.

[17]  T. Ishikawa,et al.  Prostaglandin E₂ signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. , 2011, Gastroenterology.

[18]  Keith T. Wilson,et al.  Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.

[19]  T. Wang,et al.  Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. , 2009, Cancer research.

[20]  Mathilda Lindberg,et al.  Molecular characterization of the stomach microbiota in patients with gastric cancer and controls - eScholarship , 2009 .

[21]  J. Lagergren,et al.  Oestrogen and the enigmatic male predominance of gastric cancer. , 2008, European journal of cancer.

[22]  P. O’Toole,et al.  Isolation of lactobacilli with probiotic properties from the human stomach , 2008, Letters in applied microbiology.

[23]  T. Wang,et al.  Protective role of 17 beta -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. , 2007, Carcinogenesis.

[24]  T. Wang,et al.  Inflammation, atrophy, and gastric cancer. , 2007, The Journal of clinical investigation.

[25]  M. Ohtani,et al.  Colonization Dynamics of Altered Schaedler Flora Is Influenced by Gender, Aging, and Helicobacter hepaticus Infection in the Intestines of Swiss Webster Mice , 2006, Applied and Environmental Microbiology.

[26]  E. El-Omar,et al.  Cellular and molecular aspects of gastric cancer. , 2006, World journal of gastroenterology.

[27]  E. Purdom,et al.  Molecular analysis of the bacterial microbiota in the human stomach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Chien-Jen Chen,et al.  Host-Environment Interactions: Their Impact on Progression from Gastric Inflammation to Carcinogenesis and on Development of New Approaches to Prevent and Treat Gastric Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[29]  L. Bravo,et al.  Intestinal Helminthiasis in Colombian Children Promotes a Th2 Response to Helicobacter pylori: Possible Implications for Gastric Carcinogenesis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[30]  J. Fox,et al.  Spatial Distribution and Stability of the Eight Microbial Species of the Altered Schaedler Flora in the Mouse Gastrointestinal Tract , 2004, Applied and Environmental Microbiology.

[31]  J. Virtamo,et al.  Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[32]  R. Peek,et al.  Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. , 2003, Gastroenterology.

[33]  T. Wang,et al.  Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. , 2003, Cancer research.

[34]  K. Washington,et al.  Pathology of mouse models of intestinal cancer: consensus report and recommendations. , 2003, Gastroenterology.

[35]  G. Rieder,et al.  Gastritis and Hypergastrinemia Due to Acinetobacter lwoffii in Mice , 2002, Infection and Immunity.

[36]  D. Jonkers,et al.  Non‐Helicobacter pylori bacterial flora during acid‐suppressive therapy: differential findings in gastric juice and gastric mucosa , 2001, Alimentary pharmacology & therapeutics.

[37]  C. Mowat,et al.  Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. , 2000, Gastroenterology.

[38]  F. Dewhirst,et al.  Phylogeny of the Defined Murine Microbiota: Altered Schaedler Flora , 1999, Applied and Environmental Microbiology.

[39]  H. Bartsch,et al.  N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. , 1997, Carcinogenesis.

[40]  P. Sipponen,et al.  Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. , 1996, Scandinavian journal of gastroenterology.

[41]  T. Karttunen,et al.  Helicobacter pylori-associated gastritis. Evolution of histologic changes over 10 years. , 1995, Scandinavian journal of gastroenterology.

[42]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[43]  E. C. Wood,et al.  Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. , 1984, British medical journal.

[44]  T. Wang,et al.  Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. , 2011, Gastroenterology.

[45]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[46]  L. Engstrand,et al.  Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. , 2005, International journal of systematic and evolutionary microbiology.

[47]  J. R. Kelley,et al.  Gastric cancer epidemiology and risk factors. , 2003, Journal of clinical epidemiology.

[48]  M. Blaser,et al.  Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.

[49]  T. Wang,et al.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. , 2000, Gastroenterology.